David Martin PhD Profile - Bloom Burton Analyst
291 Followers
David Martin PhD Bloom Burton
Wall Street Analyst
Success Rate
149 out of 279 ratings made a profit
Average Return
+19.00%
Average return per rating
Time Frame
Compare to
Copying David Martin PhD's trades since 2025 and holding each position for 1 Year would result in 53.41% of your transactions generating a profit, with an average return of 19.0% per rating.
Stock Rating Distribution
89.40% Buy
10.32% Hold
0.29% Sell
Distribution of David Martin PhD's ratings
Additional Information
Main Sector:General
Geo Coverage:
Best Rating
Stock:
Trillium Therapeutics
(~TRIL)
(~TRIL)
Rating:Buy
Date:Jan 08, 2020 - Jan 08, 2021
Return:+800.00%
The most profitable rating made by David Martin PhD
David Martin PhD's Stock Coverage
Viridian Therapeutics
Oct 21, 2025
Buy
Reiterated
$13.82
(-25.94% Downside)
1Ratings
-22.30%
AbCellera Biologics
Nov 19, 2025
Buy
Reiterated
$9.00
(-28.26% Downside)
6Ratings
+57.40%
Medicenna Therapeutics Corp
Dec 11, 2025
Buy
Reiterated
C$4.00
(819.54% Upside)
11Ratings
+40.74%
Helus Pharma
Jul 21, 2026
Buy
Reiterated
$47.00
(298.31% Upside)
8Ratings
+15.96%
CareRx
Jul 31, 2026
Buy
Reiterated
C$5.00
(52.44% Upside)
12Ratings
+23.32%
PYC Therapeutics Limited
Aug 05, 2026
Buy
Reiterated
AU$5.00
(109.21% Upside)
4Ratings
+25.85%
Knight Therapeutics
Aug 07, 2026
Buy
Reiterated
C$12.00
(10.80% Upside)
29Ratings
+8.81%
Medexus Pharmaceuticals Inc
Aug 12, 2026
Buy
Reiterated
C$6.50
(31.31% Upside)
14Ratings
+41.49%
HLS Therapeutics Inc
Aug 13, 2026
Buy
Reiterated
C$12.00
(193.40% Upside)
51Ratings
+8.27%
Apotex Health Corp.
Aug 13, 2026
Buy
Reiterated
C$40.00
(29.91% Upside)
3Ratings
-12.05%
List of latest recommendations made by David Martin PhD. Click to expand and see David Martin PhD's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
David Martin PhD activity FAQ
What is the performance of David Martin PhD's recommendations?
The percentage of profitable recommendations made by David Martin PhD is 53%, and the average return per transaction is 19.00%.
What stocks does David Martin PhD cover?
What was David Martin PhD's most profitable rating?
David Martin PhD’s most profitable ratings was a buy on ~TRIL stock on Jan 08, 2020 - Jan 08, 2021. The return on the trade was +800.00%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here